Publication:
Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2-breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial

Simple item page
dc.conference.dateMAY 03-05, 2022
dc.conference.titleEuropean-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress
dc.contributor.authorPrat, A.
dc.contributor.authorFalato, C.
dc.contributor.authorPare Brunet, L.
dc.contributor.authorMartinez Saez, O.
dc.contributor.authorCejalvo Andujar, J. M.
dc.contributor.authorMargeli Vila, M.
dc.contributor.authorTolosa, P.
dc.contributor.authorSalvador Bofill, F. J.
dc.contributor.authorCruz Jurado, J.
dc.contributor.authorGonzalez-Farre, B.
dc.contributor.authorSanfeliu Torres, E.
dc.contributor.authorCiruelos, E. M.
dc.contributor.authorEspinosa-Bravo, M.
dc.contributor.authorIzarzugaza Peron, Y.
dc.contributor.authorPernas Simon, S.
dc.contributor.authorEsker, S.
dc.contributor.authorFan, P-D.
dc.contributor.authorFerrero Cafiero, J. M.
dc.contributor.authorPascual, T.
dc.contributor.authorOliveira, M.
dc.contributor.authoraffiliation[Prat, A.] Hosp Clin Barcelona SOLTI IDIBAPS, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Falato, C.] IDIBAPS August Pi Sunyer Biomed Res Inst, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Pare Brunet, L.] SOLTI Canc Res Grp, Data Management, Barcelona, Spain
dc.contributor.authoraffiliation[Martinez Saez, O.] Hosp Clin Barcelona, Dept Med Oncol, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Cejalvo Andujar, J. M.] Hosp Clin Univ Valencia, Dept Med Oncol, SOLTI Canc Res Grp, Valencia, Spain
dc.contributor.authoraffiliation[Margeli Vila, M.] ICO Inst Catala Oncol Badalona Hosp Univ Germans, Dept Med Oncol, SOLTI Canc Res Grp, Badalona, Spain
dc.contributor.authoraffiliation[Tolosa, P.] Inst Invest Sanitaria Hosp 12 Octubre, Dept Med Oncol, SOLTI Canc Res Grp, Madrid, Spain
dc.contributor.authoraffiliation[Salvador Bofill, F. J.] Hosp Univ Virgen Valme, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Cruz Jurado, J.] Hosp Univ Canarias, Dept Med Oncol, San Cristobal, Spain
dc.contributor.authoraffiliation[Gonzalez-Farre, B.] Hosp Clin Barcelona, Pathol Dept, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Sanfeliu Torres, E.] Hosp Clin Barcelona, Pathol Dept, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Ciruelos, E. M.] Hosp Univ 12 Octubre, Dept Med Oncol, SOLTI Canc Res Grp, Madrid, Spain
dc.contributor.authoraffiliation[Espinosa-Bravo, M.] Vall dHebron Univ Hosp, Breast Surg Unit, Barcelona, Spain
dc.contributor.authoraffiliation[Izarzugaza Peron, Y.] Hosp Univ Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Pernas Simon, S.] ICO Inst Catala Oncol Hosp Hosp Duran, Dept Med Oncol, SOLTI Canc Res Grp, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Esker, S.] Daiichi Sankyo Inc, Global Med Dept, Basking Ridge, NJ USA
dc.contributor.authoraffiliation[Fan, P-D.] Daiichi Sankyo Pharma Dev USA, Global Oncol, Edison, NJ USA
dc.contributor.authoraffiliation[Ferrero Cafiero, J. M.] SOLTI Canc Res Grp, Dept Clin Res, Barcelona, Spain
dc.contributor.authoraffiliation[Pascual, T.] Hosp Clin Barcelona, Dept Med Oncol, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Oliveira, M.] Vall dHebron Inst Oncol VHIO, SOLTI Canc Res Grp, Breast Canc Unit, Barcelona, Spain
dc.date.accessioned2023-05-03T14:40:32Z
dc.date.available2023-05-03T14:40:32Z
dc.date.issued2022-05-05
dc.identifier.doi10.1016/j.annonc.2022.03.279
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753422007578/pdf
dc.identifier.urihttp://hdl.handle.net/10668/21909
dc.identifier.wosID792494100092
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.numberS164-S164
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePatritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2-breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number33
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen de Valme

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía